Swiss stocks - Factors to watch on October 26

ZURICH/GDANSK, Oct 26 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday:

COMPANY STATEMENTS

ROCHE HOLDING AG ROPC.S

The company said on Sunday its experimental lung cancer drug divarasib reduced the risk of death by 44% compared with existing treatments in a phase III study.

UBS GROUP AG UBSG.S

As many as 12,000 UBS jobs in Switzerland could be at risk if tougher capital rules prompt the bank to relocate, according to the Swiss Bank Employees Association, or SBPV.

CHOCOLADEFABRIKEN LINDT & SPRUENGLI AG LISN.S

The company has struggled because it misjudged how consumers would respond to price increases, the chair of the Swiss chocolate maker said, days after the company ousted its CEO over concerns about its performance.

NOVARTIS AG NOVN.S

Swiss drugmaker Novartis' oral multiple sclerosis (MS) drug remibrutinib meaningfully reduced relapses in patients, according to data presented at a medical conference in Toronto on Friday, but less than analysts had expected.

ROCHE HOLDING AG ROPC.S

The company presented Interim Phase Iii Data showing Sefaxersen significantly reduced proteinuria in people with Iga Nephropathy (Igan).

ECONOMY

SNB sight deposits due at 0900 GMT.